Name: UMIN ID:
Unique ID issued by UMIN | UMIN000030584 |
---|---|
Receipt number | R000034918 |
Scientific Title | MIRACLE (Methotrexate inadequate response patient with Rheumatoid Arthritis treated by Adalimumab in combination with Low-dose Methotrexate) Study |
Date of disclosure of the study information | 2017/12/27 |
Last modified on | 2023/04/08 11:50:42 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/12/27 08:57:54 | ||
2 | Update | 2017/12/27 16:28:32 | Date of disclosure of the study information |
|
3 | Update | 2018/06/27 22:16:54 | Classification by specialty |
|
4 | Update | 2018/06/27 22:22:51 | Institutions |
|
5 | Update | 2018/06/27 22:44:13 | Recruitment status Anticipated trial start date |
|
6 | Update | 2018/06/27 22:47:14 | Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
7 | Update | 2018/06/27 22:47:14 | Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
8 | Update | 2018/06/28 10:47:39 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
9 | Update | 2018/06/29 18:42:50 | Institutions |
|
10 | Update | 2018/08/01 13:30:32 | Key inclusion criteria Key inclusion criteria Key exclusion criteria |
|
11 | Update | 2019/01/19 17:23:12 | Key inclusion criteria Key inclusion criteria |
|
12 | Update | 2019/01/19 17:26:27 | Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 Study ID_2 Org. issuing International ID_2 Org. issuing International ID_2 |
|
13 | Update | 2019/01/19 17:27:48 | Recruitment status |
|
14 | Update | 2019/06/30 09:13:36 | Concealment |
|
15 | Update | 2019/06/30 09:19:58 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel Institutions |
|
16 | Update | 2019/06/30 09:25:37 | Date of IRB Last follow-up date |
|
17 | Update | 2020/01/24 22:01:47 | Last follow-up date |
|
18 | Update | 2020/06/03 19:23:12 | Recruitment status |
|
19 | Update | 2022/06/30 18:28:10 | Recruitment status |
|
20 | Update | 2023/04/08 11:50:43 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |